NATILE Médical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NATILE Médical
Largest movements
- Cash +€118,636
up €118,636 (+159%), from €74,637 to €193,273
mainly Net result for the year (+€113,873) and Receivables within one year (+€24,120)
- Receivables after one year +€45,000
new in 2025: €45,000
- Receivables within one year -€24,120
down €24,120 (-24.2%), from €99,660 to €75,540
of which Other amounts receivable: -€25,862
- Tangible fixed assets -€15,480
down €15,480 (-82.7%), from €18,714 to €3,234
- Deferred charges and accrued income -€4,199
down €4,199 (-71.0%), from €5,917 to €1,718
- Profit (loss) carried forward +€113,873
up €113,873 (+58.5%), from €194,761 to €308,634
- Other debts +€7,001
new in 2025: €7,001
- Gross operating margin +€21,539
up €21,539 (+15.1%), from €143,051 to €164,590
- Taxes +€6,339
up €6,339 (+21.5%), from €29,435 to €35,774
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €198,927 | €318,764 | +€119,837 | +60.2% |
| Fixed assets | 21/28 | €18,714 | €3,234 | -€15,480 | -82.7% |
| Tangible fixed assets | 22/27 | €18,714 | €3,234 | -€15,480 | -82.7% |
| Furniture and vehicles | 24 | €18,714 | €3,234 | -€15,480 | -82.7% |
| Current assets | 29/58 | €180,213 | €315,530 | +€135,317 | +75.1% |
| Amounts receivable after more than one year | 29 | - | €45,000 | +€45,000 | |
| Other amounts receivable | 291 | - | €45,000 | +€45,000 | |
| Amounts receivable within one year | 40/41 | €99,660 | €75,540 | -€24,120 | -24.2% |
| Trade receivables | 40 | €71,798 | €73,540 | +€1,742 | +2.4% |
| Other amounts receivable | 41 | €27,862 | €2,000 | -€25,862 | -92.8% |
| Cash at bank and in hand | 54/58 | €74,637 | €193,273 | +€118,636 | +159% |
| Deferred charges and accrued income | 490/1 | €5,917 | €1,718 | -€4,199 | -71.0% |
| Total equity and liabilities | 10/49 | €198,927 | €318,764 | +€119,837 | +60.2% |
| Equity | 10/15 | €197,761 | €311,634 | +€113,873 | +57.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €194,761 | €308,634 | +€113,873 | +58.5% |
| Amounts payable | 17/49 | €1,166 | €7,130 | +€5,964 | +511% |
| Amounts payable within one year | 42/48 | €1,166 | €7,130 | +€5,964 | +511% |
| Trade debts | 44 | €1,166 | €129 | -€1,037 | -88.9% |
| Suppliers | 440/4 | €1,166 | €129 | -€1,037 | -88.9% |
| Other amounts payable | 47/48 | - | €7,001 | +€7,001 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,448 | €15,480 | +€33 | +0.2% |
| Gross operating margin | 9900 | €143,051 | €164,590 | +€21,539 | +15.1% |
| Operating profit (loss) | 9901 | €127,603 | €149,110 | +€21,506 | +16.9% |
| Financial income | 75/76B | €1,492 | €607 | -€885 | -59.3% |
| Recurring financial income | 75 | €1,492 | €607 | -€885 | -59.3% |
| Financial charges | 65/66B | €40 | €70 | +€30 | +75.0% |
| Recurring financial charges | 65 | €40 | €70 | +€30 | +75.0% |
| Profit (loss) for the period before taxes | 9903 | €129,055 | €149,646 | +€20,591 | +16.0% |
| Income taxes | 67/77 | €29,435 | €35,774 | +€6,339 | +21.5% |
| Profit (loss) for the period | 9904 | €99,620 | €113,873 | +€14,253 | +14.3% |
| Profit (loss) for the period to be appropriated | 9905 | €99,620 | €113,873 | +€14,253 | +14.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.